MedAvail Holdings, Inc. MDVLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow MDVLQ
| Older periods | Sep '22 | Dec '22 | Mar '23 | Jun '23 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
3.18 | 0.45 | 0.53 | 0.51 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(5.37) | (1.85) | (4.42) | (5.03) | |
P/B ratio |
1.98 | 0.92 | 5.52 | 0.96 | |
Price to Tangible BV |
2.09 | 0.94 | 6.14 | 0.98 | |
EV/Sales |
2.29 | 0.29 | 0.12 | 0.20 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.87) | (0.26) | (0.13) | (0.28) | |
EV/FCF |
(0.82) | (0.25) | (0.13) | (0.26) | |
Quick Ratio |
4.27 | 2.11 | 3.83 | 3.69 | |
Current Ratio |
5.58 | 4.84 | 6.34 | 6.51 | |
Net Debt/EBITDA |
1.80 | 0.29 | 4.31 | 3.44 | |
Debt/Assets |
21.02% | 16.62% | 4.68% | 5.73% | |
Debt/Equity |
0.33 | 0.26 | 0.40 | 0.07 | |
Asset Turnover |
0.38 | 1.21 | 1.37 | 1.05 | |
Operating CF/Net income |
0.98 | 0.94 | 0.30 | 0.76 | |
Capex/Depreciation |
(0.09) | (0.25) | (0.02) | (0.19) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.55% | 1.49% | 28.39% | 35.80% | |
Selling, General and Administrative Expense of Revenue |
71.66% | 43.37% | 821.29% | 1,107.90% | |
Intangible Assets out of Total Assets |
0.03 | 0.01 | 0.01 | 0.02 | |
Share Based Compensation of Revenue |
4.93% | 1.80% | 99.68% | 94.07% | |
Graham Net Nets |
0.34 | 0.86 | 0.04 | 0.92 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(141.75%) | (294.52%) | (237.26%) | (234.26%) | |
Free Cash Flow Yield |
(87.88%) | (260.16%) | (180.78%) | (150.26%) | |
Revenue per Share |
7.16 | 23.44 | 0.39 | 0.23 | |
Operating CF per Share |
(7.23) | (7.89) | (3.25) | (2.44) | |
Capex per Share |
(0.11) | (0.31) | (0.01) | (0.06) | |
Free Cash Flow per Share |
(7.33) | (8.20) | (3.26) | (2.50) | |
Cash per Share |
17.41 | 9.21 | 12.13 | 8.36 | |
Shareholders Equity per Share |
19.56 | 15.83 | 2.60 | 12.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.56 | 15.83 | 2.60 | 12.82 | |
Free Cash Flow |
(11.74) | (10.79) | (5.23) | (4.49) | |
Working Capital |
32.34 | 22.81 | 27.40 | 22.89 | |
Capital Expenditures |
(0.17) | (0.41) | (0.02) | (0.11) | |
Net Current Asset Value |
20.85 | 16.44 | 0.99 | 20.19 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.03 | 0.27 | |
Net Profit Margin |
(103.01%) | (35.89%) | (2,795.16%) | (1,429.88%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.67 | 0.80 | 0.98 | 1.18 | |
Average Payables |
4.54 | 1.65 | 4.71 | 1.83 | |
Average Inventory |
5.33 | 6.37 | 6.89 | 7.84 | |
Average Assets |
50.97 | 35.64 | 31.70 | 41.37 | |
Average Common Equity |
31.26 | 19.95 | 5.39 | 27.92 |
Columns are period end dates